Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 26, 2022

SELL
$58.27 - $118.99 $697,200 - $1.42 Million
-11,965 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$100.76 - $138.36 $1.21 Million - $1.66 Million
11,965 New
11,965 $1.42 Million

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $784M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Vista Finance, LLC Portfolio

Follow Vista Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vista Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vista Finance, LLC with notifications on news.